But this Wall Street Journal report from last week adds a new twist: Clinical Studies being sabotaged as drugs used in trials dry-up:
Drug Shortages Threaten Cancer Research
Wall Street Journal
This is subscriber-only content. But we are allowed to view a tease, stating:
WASHINGTON—Cancer-drug shortages in the U.S. have caused hundreds of clinical trials to be stopped or delayed, threatening progress on new treatments, a top health official told Congress Friday.
Howard Koh, assistant secretary of health for the Department of Health and Human Services, said drug shortages are "dramatically affecting clinical trials." Dr. Koh testified Friday before the House Energy and Commerce Subcommittee on Health during a hearing on drug shortages...
Here is a LINK to the WSJ site.
Unfortunate. Feel good and keep smiling! Pat